cam a22 4 4500 508208483 CHVBK 20201001101415.0 180302s2012 sz ||||i100 |eng|d 978-92-4-120965-6 92-4-120965-8 (NEBIS)011131557 (SNL)991017624529703976 (OCoLC)808811919 (Sz)1691401-41snl_51 (Sz)vtls001691401 (Sz)001691401 NUI eng SzZuIDS NEBIS ETH-BIB rda RA8 .A25 no. 965 610 23sdnb Weltgesundheitsorganisation Expert Committee on the Selection and Use of Essential Medicines (DE-588)5552869-7 Verfasser aut The selection and use of essential medicines report of the WHO Expert Committee, 2011 (including the 17th WHO Model List of Essential Medicines and the 3rd WHO Model List of Essential Medicines for Children) 17th WHO Model List of Essential Medicines Seventeenth WHO Model List of Essential Medicines 3rd WHO Model List of Essential Medicines for Children Third WHO Model List of Essential Medicines for Children Geneva World Health Organization [2012] xiv, 249 pages WHO technical report series 965 965 (NEBIS)000023541 278782957 The 18th Meeting of the WHO Expert Committee on the Selection and Use of Essential Medicine took place in Accra, Ghana on 21-25 March 2011 Includes bibliographical references (pages 227-249) Drugs Standards Congresses Medicine Formulae, receipts, prescriptions Congresses Drug utilization Standards Congresses Drugs, Essential administration & dosage (DNLM)D018954Q000008 Drug Information Services (DNLM)D004346 Drug Utilization standards (DNLM)D004363Q000592 Formularies as Topic (DNLM)D005569 Pharmaceutical Preparations standards (DNLM)D004364Q000592 ARZNEIMITTELGLIEDERUNG NACH IHRER HAUPTWIRKUNG ger (ETHUDK)000026663 ethudk ARZNEIMITTELVERABREICHUNG + ARZNEIMITTELANWENDUNGSFORMEN (PHARMAKOLOGIE) ger (ETHUDK)000026638 ethudk DOSIS-WIRKUNG BEZIEHUNG UND DOSIMETRIE (PHARMAKOLOGIE) ger (ETHUDK)000026628 ethudk LISTEN, AUFSTELLUNGEN IM ALLGEMEINEN (DOKUMENTENTYP) ger (ETHUDK)000000109 ethudk Konferenzschrift Accra 2011 gnd-content u ARZNEIMITTELGLIEDERUNG NACH IHRER HAUPTWIRKUNG ger 615.2 nebis E1 u ARZNEIMITTELVERABREICHUNG + ARZNEIMITTELANWENDUNGSFORMEN (PHARMAKOLOGIE) ger 615.032 nebis E1 u DOSIS-WIRKUNG BEZIEHUNG UND DOSIMETRIE (PHARMAKOLOGIE) ger 615.015.3 nebis E1 u LISTEN, AUFSTELLUNGEN IM ALLGEMEINEN (DOKUMENTENTYP) ger (083.81) nebis E1 u PHARMACEUTICAL DRUG CLASSIFICATION ACCORDING TO MAIN EFFECTS eng 615.2 nebis E1 u CLASSIFICATION DES MÉDICAMENTS SELON LES EFFETS MAJEURS fre 615.2 nebis E1 u DRUG ADMINISTRATION + TYPES OF DRUG ADMINISTRATION (PHARMACOLOGY) eng 615.032 nebis E1 u APPLICATIONS DE MÉDICAMENTS + FORMES D'APPLICATION DES MÉDICAMENTS (PHARMACOLOGIE) fre 615.032 nebis E1 u DOSAGE + RELATION ENTRE DOSAGE ET ACTION DES MÉDICAMENTS (PHARMACOLOGIE) fre 615.015.3 nebis E1 u DOSISMETRY + DOSE RESPONSE + DOSAGE (PHARMACOLOGY) eng 615.015.3 nebis E1 u LISTS, SCHEDULES IN GENERAL (DOCUMENT TYPE) eng (083.81) nebis E1 u LISTES EN GÉNÉRAL (TYPE DE DOCUMENT) fre (083.81) nebis E1 sb 2012/22 610 ge snl-sb Technical report series Weltgesundheitsorganisation 965 (Sz)000067788 BK020800 XK020000 XK020000 134 E01 SNL NB001 NB001 N 323870 NB10010 NEBIS 110 2- Weltgesundheitsorganisation Expert Committee on the Selection and Use of Essential Medicines (DE-588)5552869-7 Verfasser aut NEBIS 490 0- WHO technical report series 965 965 (NEBIS)000023541 278782957 SNL 110 2- WHO Expert Committee on the Selection and Use of Essential Medicines Meeting (18 2011 Accra, Ghana) SNL 490 1- WHO technical report series 0512-3054 965 SNL 710 2- Weltgesundheitsorganisation (DE-588)1007857-5 SNL 711 2- Kongress (2011 Accra, Ghana) SNL 830 -- Technical report series Weltgesundheitsorganisation 965 (Sz)000067788 SNL 856 41 https://opac.admin.ch/toc/toc001691401.pdf Inhaltsverzeichnis NEBIS EAD50 https://opac.nebis.ch/objects/pdf03/e16_978-92-4-120965-6_01.pdf Titelblatt und Inhaltsverzeichnis VIEW pdf SWISSBIB 507627873